Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04147585 · ClinicalTrials.gov registry record · NA

Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT04147585: Completed NA study, sponsored by Stanford University.

NCT04147585 is a NA study that has completed, run by Stanford University. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04147585, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

The purpose of this study is to see how an Intermittent Calorie Reduced Diet (IRCD) that mimics fasting (also known as a fasting mimicking diet, FMD) effects inflammation in patients with mild to moderate Crohn's disease (CD). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA). Research on dietary interventions and CD are very limited. Diets that mimick fasting have been studied with support of the National Institute of Health and published in leading journals. This research investigates whether markers of inflammation decrease and/or quality of life increases after five-day periods of the IRCD, and may provide rationale for its use to treat CD.

Interventions

  • OTHER Intermittent Reduced Calorie Diet (IRCD)

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2019-12-18
Est. Completion 2024-05-06
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04147585

The ClinicalTrials.gov registry entry for NCT04147585 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intermittent Reduced Calorie Diet (IRCD) is the first listed.

NCT04147585 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04147585 about?

NCT04147585 is a clinical study titled "Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease". The purpose of this study is to see how an Intermittent Calorie Reduced Diet (IRCD) that mimics fasting (also known as a fasting mimicking diet, FMD) effects inflammation in patients with mild to moderate Crohn's disease (CD). The diet may allow users to receive the benefits of fasting while also be...

What is the current status of trial NCT04147585?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2019-12-18. Estimated completion is 2024-05-06.

What interventions are being tested in trial NCT04147585?

The interventions under investigation include: Intermittent Reduced Calorie Diet (IRCD) (OTHER).

Who is sponsoring clinical trial NCT04147585?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.